2nd Quarter - Report

AMERICAN ASSOCIATION FOR CANCER RESEARCH for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2027 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.

LobbyistCovered position, as disclosed
MATTHEW GONTARCHICK —
CARLY MCCALLIE —
BLAKE WILLIAM ROSTINE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention

LobbyistCovered position, as disclosed
MATTHEW GONTARCHICK —
CARLY MCCALLIE —
BLAKE WILLIAM ROSTINE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Tobacco TOB

Tobacco control and prevention Tobacco cessation

LobbyistCovered position, as disclosed
MATTHEW GONTARCHICK —
CARLY MCCALLIE —
BLAKE WILLIAM ROSTINE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Reducing cancer disparities Cancer survivorship

LobbyistCovered position, as disclosed
MATTHEW GONTARCHICK —
CARLY MCCALLIE —
BLAKE WILLIAM ROSTINE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.